ABSTRACT OF THE DISCLOSUREThis invention is directed to 17.beta.-(cyclopropyloxy)-androst-5-en-3.beta.-ol and related compounds and also to amethod for using such compounds in the treatment ofandrogen-dependent disorders. The ethers are prepared byusing the Simmons-Smith reaction and an appropriate vinylether.
展开▼